Moderna, Merck mRNA Cancer Vaccine Breakthrough Shows Broad Promise

Scientists are hopeful about a new mRNA cancer vaccine developed by Merck & Co. and Moderna Inc., which has shown success in preventing melanoma from returning and could usher in a new era of cancer vaccines. This development brings researchers closer to using vaccines to train the immune system to destroy cancer cells.